Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 5

Results: 13

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 613, doi. 10.1007/s11523-021-00837-y

By:

Evans, Rachel;
Hawkins, Neil;
Dequen-O'Byrne, Pascale;
McCrea, Charles;
Muston, Dominic;
Gresty, Christopher;
Ghate, Sameer R.;
Fan, Lin;
Hettle, Robert;
Abrams, Keith R.;
de Bono, Johann;
Hussain, Maha;
Agarwal, Neeraj

Publication type:

Article

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 687, doi. 10.1007/s11523-021-00839-w

By:

Lamb, Yvette N.

Publication type:

Article

A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 569, doi. 10.1007/s11523-021-00835-0

By:

Moore, Kathleen N.;
Hong, David S.;
Patel, Manish R.;
Pant, Shubham;
Ulahannan, Susanna V.;
Jones, Suzanne;
Meric-Bernstam, Funda;
Wang, Judy S.;
Aljumaily, Raid;
Hamilton, Erika P.;
Wittchen, Erika S.;
Wang, Xuejing;
Lin, Aimee Bence;
Bendell, Johanna C.

Publication type:

Article

Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 653, doi. 10.1007/s11523-021-00834-1

By:

Rimini, Margherita;
Yoo, Changhoon;
Lonardi, Sara;
Masi, Gianluca;
Granito, Alessandro;
Bang, Yeonghak;
Rizzato, Mario Domenico;
Vivaldi, Caterina;
Ielasi, Luca;
Kim, Hyung-Don;
Bergamo, Francesca;
Salani, Francesca;
Leoni, Simona;
Ryoo, Baek-Yeol;
Ryoo, Min-Hee;
Burgio, Valentina;
Cascinu, Stefano;
Casadei-Gardini, Andrea

Publication type:

Article

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 601, doi. 10.1007/s11523-021-00826-1

By:

Brufsky, Adam;
Liu, Xianchen;
Li, Benjamin;
McRoy, Lynn;
Layman, Rachel M.

Publication type:

Article

The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 537, doi. 10.1007/s11523-021-00840-3

By:

Stege, Henner;
Haist, Maximilian;
Nikfarjam, Ulrike;
Schultheis, Michael;
Heinz, Jaqueline;
Pemler, Saskia;
Loquai, Carmen;
Grabbe, Stephan

Publication type:

Article

Isatuximab: A Review of Its Use in Multiple Myeloma.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 675, doi. 10.1007/s11523-021-00827-0

By:

Frampton, James E.

Publication type:

Article

Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 663, doi. 10.1007/s11523-021-00830-5

By:

Ramsey, Haley E.;
Stengel, Kristy;
Pino, James C.;
Johnston, Gretchen;
Childress, Merrida;
Gorska, Agnieszka E.;
Arrate, Pia M.;
Fuller, Londa;
Villaume, Matthew;
Fischer, Melissa A.;
Ferrell Jr., P. Brent;
Roe, Caroline E.;
Zou, Jing;
Lubbock, Alexander L. R.;
Stubbs, Matthew;
Zinkel, Sandra;
Irish, Jonathan M.;
Lopez, Carlos F.;
Hiebert, Scott;
Savona, Michael R.

Publication type:

Article

A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 633, doi. 10.1007/s11523-021-00832-3

By:

Desai, Kunal;
Brown, Landon;
Wei, Wei;
Tucker, Matthew;
Kao, Chester;
Kinsey, Emily;
Rini, Brian;
Beckermann, Kathryn;
Zhang, Tian;
Ornstein, Moshe C.

Publication type:

Article

Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 591, doi. 10.1007/s11523-021-00823-4

By:

Wang, Jiani;
Zhang, Qingyuan;
Li, Qiao;
Mu, Yuxin;
Jing, Jing;
Li, Huiping;
Li, Wei;
Wang, Jingfen;
Yu, Guohua;
Wang, Xian;
Ouyang, Quchang;
Hao, Jing;
Lu, Liang;
Zhou, Li;
Guan, Jin;
Li, Qing;
Xu, Binghe

Publication type:

Article

Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 643, doi. 10.1007/s11523-021-00829-y

By:

Fiala, Ondřej;
Ostašov, Pavel;
Rozsypalová, Aneta;
Hora, Milan;
Šorejs, Ondřej;
Šustr, Jan;
Bendová, Barbora;
Trávníček, Ivan;
Filipovský, Jan;
Fínek, Jindřich;
Büchler, Tomáš

Publication type:

Article

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 625, doi. 10.1007/s11523-021-00828-z

By:

Santoni, Matteo;
Massari, Francesco;
Grande, Enrique;
Procopio, Giuseppe;
Matrana, Marc R.;
Rizzo, Mimma;
De Giorgi, Ugo;
Basso, Umberto;
Milella, Michele;
Iacovelli, Roberto;
Aurilio, Gaetano;
Incorvaia, Lorena;
Buti, Sebastiano;
Caffo, Orazio;
Fornarini, Giuseppe;
Carrozza, Francesco;
Mollica, Veronica;
Rizzo, Alessandro;
Farag, Fady;
Molina-Cerrillo, Javier

Publication type:

Article

Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

Published in:

Targeted Oncology, 2021, v. 16, n. 5, p. 553, doi. 10.1007/s11523-021-00824-3

By:

Petrelli, Fausto;
Morelli, Anna Maria;
Luciani, Andrea;
Ghidini, Antonio;
Solinas, Cinzia

Publication type:

Article